JUPITER NEUROSCIENCES, INC.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
JUNS$2.22+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements Of Cash Flows
JUPITER NEUROSCIENCES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| March 31, 2026 · March 31, 2025 | ||||
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net Loss | $(2,061,958) | $(1,528,867) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Gain on change in fair value of convertible notes | (1,282) | - | ||
| Interest expense paid through sale of common stock | 131,479 | - | ||
| Amortization of prepaid contracts | 189,041 | 189,041 | ||
| Stock-based compensation | 500,992 | 421,454 | ||
| Change in operating lease right of use asset and lease liabilities | (1,132) | (659) | ||
| Decreases (increases) in operating assets and liabilities: | ||||
| Accounts receivable | 2,637 | - | ||
| Prepaid contracts | - | (24,106) | ||
| Decrease in inventory | 11,722 | - | ||
| Other current assets | (26,154) | - | ||
| Accounts payable and accrued expenses | (164,010) | (113,552) | ||
| Accrued compensation | 25,255 | (7,435) | ||
| Deferred revenue | (735) | - | ||
| Refund liability | 1,874 | - | ||
| Accrued interest | (39,829) | 1,083 | ||
| Net cash used in operating activities | (1,432,100) | (1,063,041) | ||
| Cash Flows from Financing Activities: | ||||
| Proceeds from exercise of stock options | 5,507 | - | ||
| Net cash provided by financing activities | 5,507 | - | ||
| Net Change in Cash | (1,426,593) | (1,063,041) | ||
| Beginning of period | 3,789,342 | 3,769,510 | ||
| End of period | $2,362,749 | $2,706,469 | ||
| Supplemental disclosure of cash flow information: | ||||
| Cash paid for interest | $ | - | $146 | |
| Schedule of Non-Cash Investing and Financing Activities: | ||||
| Stock issued in connection with service agreement | $46,750 | $ | - | |
| Payment of convertible note from issuance of common stock | $472,375 | $ | - | |
| Stock issued in connection with interest payment | $131,479 | $ | - | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.